Advectus Life Sciences is an emerging pharmaceutical company engaged in developing a nanoparticle technology for drug delivery treatment targeting specific cancers – with an initial focus on brain tumors. Advectus needed a name, a brand and to be positioned as an emerging pharmaceutical development company to build awareness in the industry and with potential partners, investors and the media.
As part of a complete branding and awareness program NextPhase created the name – Advectus Life Sciences. We then produced a complete communications program to convey the vision to all stakeholders. The program included a corporate identity, informative website, corporate brochure, presentation folder, multimedia show, investor profile, media kit, and a trade show display. Upon completion of the marketing tools, NextPhase commenced a public relations program targeted at business and investment media.
The successful development of the new marketing tools and implementation of the public relations program positioned Advectus in the investment marketplace in both North America and Europe. It also helped open the door to alliances with the Alberta Cancer Board, Aventis and Johns Hopkins Hospital.